Success Metrics

Clinical Success Rate

100.0%

Based on 3 completed trials

Completion Rate

100%(3/3)

Active Trials

2(33%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

67%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

N/ANon-phased studies

4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(3)

Completed(3)

Detailed Status

Completed3

Not yet recruiting1

Recruiting1

Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

not_yet_recruiting117%

completed350%

recruiting117%

active_not_recruiting117%

Recent Activity

2 active trials

Showing 5 of 6

recruiting

Post-Stroke Sensory Reweighting on Walking and Balance Outcomes

NCT06727097

active_not_recruitingnot_applicable

MRI Study of the Mechanisms Underlying Irreversible Disability in Multiple Sclerosis

NCT03356366

not_yet_recruiting

Clinical Trials (6)

Showing 6 of 6 trials

NCT06727097

Post-Stroke Sensory Reweighting on Walking and Balance Outcomes

Recruiting

NCT03356366Not Applicable

MRI Study of the Mechanisms Underlying Irreversible Disability in Multiple Sclerosis

Active Not Recruiting

NCT06516016

Multimodal Markers of Neurodegenerative Disorders at Presymptomatic Stages

Not Yet Recruiting

NCT02576821Not Applicable

Hippocampal Sclerosis and Amnesia Not Due to Alzheimer's Disease

Completed

NCT03215420Not Applicable

Comparison of 3 Methods to Diagnose Endolymphatic Hydrops in Meniere's Disease

Completed

NCT02885883Not Applicable

Non-invasive Quantification of Atrial Fibrosis by MRI in Atrial Fibrillation

Completed

All 6 trials loaded

Drug Details

Intervention Type: DIAGNOSTIC TEST
Total Trials: 6